Translational Development Acquisition Corp. (TDACW)
NASDAQ
1.85
+0.26 (+16.35%)
Closed
Sep 4, 2026
Day's Range
1.851.85
52 wk Range
0.17002.70
Financial Statements - TDACW - Translational Development Acquisition Corp.
Revenue
0
Net Income
6.36M▲ 9059.7%
EBITDA
-8.25M▼ 2464.9%
Free Cash Flow
-608.38K▲ 28.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Sales | 0 | 0 | 0 |
| Cost of Goods | - | - | - |
| Gross Profit | - | - | - |
 Operating Expense | - | - | - |
| Operating Income | -944.53K | -196.35K | -485.55K |
| Non-Operating Interest | - | - | - |
| Other Income Expense | 7.30M | 125.34K | - |
| Pre Tax Income | 6.36M | -71.01K | -485.55K |
| Income Tax | - | - | - |
| Net Income | 6.36M | -71.01K | -485.55K |
| EPS Basic | - | - | - |
| EPS Diluted | - | - | - |
| Basic Shares Outstanding | - | - | - |
| Diluted Shares Outstanding | - | - | - |
| Ebit | -944.53K | -196.35K | -485.55K |
| Ebitda | -8.25M | -321.70K | -485.55K |
| Net Income Continuous Operations | 6.36M | -71.01K | -485.55K |
| Minority Interests | - | - | - |
| Preferred Stock Dividends | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
